ALPS ADVISORS INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$796,000
-10.9%
9,239
-7.7%
0.01%
-11.1%
Q2 2022$893,000
-54.2%
10,007
-42.2%
0.01%
-57.1%
Q1 2022$1,949,000
-34.8%
17,324
-10.4%
0.02%
-38.2%
Q4 2021$2,987,000
+4.9%
19,340
-5.4%
0.03%
+25.9%
Q3 2021$2,847,000
-0.6%
20,434
-6.4%
0.03%
+8.0%
Q2 2021$2,863,000
-35.4%
21,824
-25.0%
0.02%
-41.9%
Q1 2021$4,434,000
+53.4%
29,085
+0.1%
0.04%
+30.3%
Q4 2020$2,890,000
+47.9%
29,060
+41.8%
0.03%
+13.8%
Q3 2020$1,954,000
-20.2%
20,500
-6.4%
0.03%
-12.1%
Q2 2020$2,449,000
+12.2%
21,898
-27.0%
0.03%
-2.9%
Q1 2020$2,182,000
-40.8%
30,011
-15.1%
0.03%
+17.2%
Q4 2019$3,687,000
-2.3%
35,352
-6.8%
0.03%0.0%
Q3 2019$3,775,000
-25.2%
37,928
-14.3%
0.03%
-21.6%
Q2 2019$5,049,000
-24.1%
44,232
-16.4%
0.04%
-21.3%
Q1 2019$6,655,000
-3.6%
52,937
+4.1%
0.05%
-13.0%
Q4 2018$6,900,000
-35.8%
50,847
+29.9%
0.05%
-23.9%
Q3 2018$10,748,000
+68.5%
39,156
+27.2%
0.07%
+69.0%
Q2 2018$6,378,000
+36.4%
30,784
+8.8%
0.04%
+13.5%
Q1 2018$4,675,000
+46.0%
28,305
+21.0%
0.04%
+68.2%
Q4 2017$3,202,000
+14.2%
23,386
+13.5%
0.02%
+10.0%
Q3 2017$2,805,000
+22.4%
20,603
+9.1%
0.02%
+25.0%
Q2 2017$2,292,000
+20.7%
18,883
+5.3%
0.02%
+23.1%
Q1 2017$1,899,000
-7.0%
17,941
-10.7%
0.01%
-13.3%
Q4 2016$2,041,000
-24.8%
20,084
-24.5%
0.02%
-31.8%
Q3 2016$2,713,000
-31.7%
26,586
-20.2%
0.02%
-37.1%
Q2 2016$3,974,000
+38.6%
33,320
+24.4%
0.04%
+16.7%
Q1 2016$2,867,000
-15.5%
26,775
-14.4%
0.03%
-9.1%
Q4 2015$3,393,000
-89.1%
31,294
-13.6%
0.03%0.0%
Q3 2015$31,024,000
+1053.7%
36,222
+35.9%
0.03%
+43.5%
Q2 2015$2,689,000
+107.2%
26,651
+58.4%
0.02%
+109.1%
Q1 2015$1,298,000
+99.7%
16,828
+60.4%
0.01%
+57.1%
Q4 2013$650,000
+179.0%
10,494
+94.9%
0.01%
+133.3%
Q3 2013$233,0005,3840.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders